Parkville, MD, United States of America

Purevdorj B Olkhanud

This inventor holds 5 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Purevdorj B Olkhanud. Retrieved from https://idiyas.com/inventor/purevdorj-b-olkhanud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Parkville, MD (US) (2014 - 2017)
  • Baltimore, MD (US) (2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Purevdorj B Olkhanud: Biomedical Inventions and Patent Contributions

Introduction

Purevdorj B Olkhanud is an inventor based in Parkville, Maryland. His patent work includes biomedical approaches to gene silencing and immune regulation. He is associated with the U.S. Department of Health and Human Services, represented by the Secretary.

Latest Patents

Olkhanud’s listed patent portfolio includes 5 patents. Two of his latest patent topics are:

- Compositions and Methods for Delivering Inhibitory Oligonucleotides describes complexes combining inhibitory nucleic acids with a targeting polypeptide consisting of a cell-surface receptor ligand. The disclosed compositions and methods are intended to support targeted delivery, gene-expression silencing, and potential treatment or prevention of disease.

- Regulatory B Cells (tBREGS) and Their Use concerns regulatory B cells that express CD25, B220, and CD19 and can suppress resting and activated T cells through cell contact. The patent describes methods for generating and using these cells, including potential applications involving immune-mediated disorders, transplantation, inflammation, and cancer.

Career Highlights

Olkhanud’s patent contributions address areas of biomedical research with potential relevance to therapeutic development. His work on inhibitory oligonucleotide delivery focuses on targeting cells, while his research on regulatory B cells explores ways to influence immune responses.

Collaborations

Olkhanud’s listed coworkers include Bira Arya and Juan Espinoza. His patent work is associated with the U.S. Department of Health and Human Services.

Conclusion

Purevdorj B Olkhanud’s inventions focus on targeted gene silencing and immune regulation, reflecting the potential of biomedical research to inform new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…